Tolgabide

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Tolgabide
Tolgabide.svg
Clinical data
ATC code
  • none
Legal status
Legal status
  • In general: uncontrolled
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
Formula C18H18Cl2N2O2
Molar mass 365.25 g/mol
3D model (Jmol)

Tolgabide INN (SL-81.0142) is a drug which was patented by Synthélabo as an anticonvulsant but was never marketed.[1] It is an analogue of progabide and acts similarly to it as a prodrug of GABA, and therefore as an indirect agonist of the GABA receptors.[1][2]

Synthesis[edit]

Tolgabide synthesis: J. P. Kaplan, Synthélabo, DE 3242442  (1983)

See also[edit]

References[edit]